TP53 and cancer: We observed a common set of early clonal mutational mechanisms including frequent chromothripsis, and near ubiquitous early gain of mutant TP53. The early copy number gain associated TP53 LOH in LFS tumors relative to somatic TP53 mutant cancers may be explained by the increased selective pressures for a “second hit” to TP53 when a first hit exists from conception.